Gemcitabine-based combination treatment of pancreatic cancer

被引:44
|
作者
Heinemann, V [1 ]
机构
[1] Klinikum Grosshadern, Med Clin 3, D-81377 Munich, Germany
关键词
D O I
10.1053/sonc.2002.30749
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:25 / 35
页数:11
相关论文
共 50 条
  • [21] Correlation of basal EGFR expression with pancreatic cancer grading but not with clinical outcome after gemcitabine-based treatment
    Funel, N.
    Vasile, E.
    Del Chiaro, M.
    Boggi, U.
    Falcone, A.
    Campani, D.
    Scarpa, A.
    Giovannetti, E.
    ANNALS OF ONCOLOGY, 2011, 22 (02) : 482 - U265
  • [22] Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines
    Waissi, Waisse
    Ame, Jean-Christophe
    Mura, Carole
    Noel, Georges
    Burckel, Helene
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (13)
  • [23] Gemcitabine-based chemotherapy in advanced-metastatic and/or unresectable pancreatic cancer.
    Samelis, GF
    Areovimata, A
    Matsiakou, F
    Zografos, G
    Papakostas, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 376S - 376S
  • [24] The role of gemcitabine alone and in combination in the treatment of pancreatic cancer
    Oettle, H
    Arnold, D
    Hempel, C
    Riess, H
    ANTI-CANCER DRUGS, 2000, 11 (10) : 771 - 786
  • [25] Preoperative Gemcitabine-based Chemoradiation Therapy for Resectable and Borderline Resectable Pancreatic Cancer
    Ravikumar, Reena
    Fusai, Giuseppe
    ANNALS OF SURGERY, 2015, 262 (06) : E103 - E103
  • [26] Efficacy and tolerance of gemcitabine-based regimens in elderly patients with advanced pancreatic cancer
    Marechal, Raphael
    Demols, Anne
    Gay, France
    Arvanitakis, Marianna
    Hendlisz, Alain
    Van Laethem, Jean-Luc
    ANNALS OF ONCOLOGY, 2006, 17 : 326 - 326
  • [27] Helical tomotherapy and concurrent gemcitabine-based chemotherapy for locally advanced pancreatic cancer
    Seong, Jinsil
    Chang, Jisuk
    Song, Siyoung
    Keum, Woong
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [28] Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable and Borderline Resectable Pancreatic Cancer
    Takahashi, Hidenori
    Ohigashi, Hiroaki
    Gotoh, Kunihito
    Marubashi, Shigeru
    Yamada, Terumasa
    Murata, Masayuki
    Ioka, Tatsuya
    Uehara, Hiroyuki
    Yano, Masahiko
    Ishikawa, Osamu
    ANNALS OF SURGERY, 2013, 258 (06) : 1040 - 1050
  • [29] Cytoreductive Surgery for Pancreatic Cancer Improves Overall Outcome of Gemcitabine-Based Chemotherapy
    Bahra, Marcus
    Pratschke, Johann
    Klein, Fritz
    Neuhaus, Peter
    Boas-Knoop, Sabine
    Puhl, Gero
    Denecke, Timm
    Pullankavumkal, Joyce R.
    Sinn, Marianne
    Riess, Hanno
    Pelzer, Uwe
    PANCREAS, 2015, 44 (06) : 930 - 936
  • [30] Gemcitabine-Based Chemoradiotherapy Gets Improved with PARP Inhibitor in Pancreatic Cancer Cells
    Waissi, W.
    Burckel, H.
    Nicol, A.
    Larderet, G.
    Noel, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E160 - E160